Total Funding
52
44
Total FundingSeries A raised
Growth Score
-2 pts
Heat Score
-2 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
51424
Mironid is a drug discovery company focused on therapeutics for degenerative kidney diseases, chronic inflammatory diseases, and cancer.
- Elizabeth Fairley: Business Development Director
- Steve Felstead: Chief Medical Officer
About the Company
Mironid is a biotechnology company that focuses on drug discovery and development. Mironid builds and advances a pipeline of drug development programs targeting cAMP-degrading phosphodiesterase enzymes. The goal is to create novel and differentiated therapies for various diseases with significant unmet medical needs.
The company specializes in
identifying and validating novel drug targets, particularly in therapeutic areas such as cancer and neurodegenerative diseases. Mironid's work often involves using advanced technologies and methodologies to enhance the drug discovery process, aiming to bring innovative treatments to market more efficiently.
